NEW YORK (GenomeWeb News) – Exact Sciences has raised $137.7 million in net proceeds from a public offering of 11.5 million shares of common stock.

The firm priced the shares at $12.75 each, which brought in gross proceeds of $146.6 million. Exact Sciences priced the offering of 10 million shares last week. The underwriters on the offering exercised their 1.5 million-share overallotment option in full.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.